Article
TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19.
The Journal of infectious diseases - 13 Sept 2022
Fricke-Galindo Ingrid, Buendía-Roldán Ivette, Ruiz Andy, Palacios Yadira, Pérez-Rubio Gloria, de Jesus Hernández-Zenteno Rafael, Reyes-Melendres Felipe, Zazueta-Márquez Armando, Alarcón-Dionet Aimé, Guzmán-Vargas Javier, Bravo-Gutiérrez Omar Andrés, Quintero-Puerta Teresa, Gutiérrez-Pérez Ilse Adriana, Nava-Quiroz Karol J, Bañuelos-Flores José Luis, Mejía Mayra, Rojas-Serrano Jorge, Ramos-Martínez Espiridión, Guzmán-Guzmán Iris Paola, Chávez-Galán Leslie, Falfán-Valencia Ramcés
Abstract excerpt
BACKGROUND: The impact of genetic variants in the expression of tumor necrosis factor-α (TNF-α) and its receptors in coronavirus disease 2019 (COVID-19) severity has not been previously explored. We evaluated the association of TNF (rs1800629 and rs361525), TNFRSF1A (rs767455 and rs1800693), and TNFRSF1B ( and ) variants with COVID-19 severity, assessed as invasive mechanical ventilation (IMV)...
